H3K18 lactylation in pancreatic cancer: promising yet unproven ‒ a call for validation
Open Access
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancerClinics, 2024
- Metabolic regulation of gene expression by histone lactylationNature, 2019
- Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic CancerNew England Journal of Medicine, 2019
- NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivorsEuropean Journal of Cancer, 2019
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- Phases of Biomarker Development for Early Detection of CancerJNCI: Journal of the National Cancer Institute, 2001